Analyst Ratings for Cartesian Therapeutics (RNAC)
RNAC Rating Summary
RNAC Price Target Summary
- Highest: $44.00 (BTIG)
- Lowest: $30.00 (H.C. Wainwright)
- Average: $37.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$37.33 (+445%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$37.33 (+445%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2025 | Wedbush | Martin Fan | New Coverage | Outperform (N/A) |
38.00 (N/A) |
11.30 (6.85) |
-39.38% | Details |
| 12/19/2024 | BTIG » Updated 11/14/2025 |
Julian Harrison | New Coverage | Buy (N/A) |
44.00 (42.00) |
16.92 (6.85) |
-59.52% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
